Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of 2nd Dose Varicella Vaccine at Different Intervals
NCT02173899Phase 4Completed
- Sponsor
- Changchun Keygen Biological Products Co., Ltd.
- Start
- Jun 2014
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ivermectin in varicella (VZV), sponsored by Changchun Keygen Biological Products Co., Ltd.. Started Jun 2014; status: completed.
02
Drugs
ivermectin
03
Conditions
varicella (VZV)
Beyond the preview
Go deeper on NCT02173899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02173899.